Olof Strandberg
Overview
Explore the profile of Olof Strandberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
3837
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karlsson L, Vogel J, Arvidsson I, Astrom K, Strandberg O, Seidlitz J, et al.
Alzheimers Dement
. 2025 Feb;
21(2):e14600.
PMID: 39985487
Introduction: Tau positron emission tomography (PET) is a reliable neuroimaging technique for assessing regional load of tau pathology in the brain, but its routine clinical use is limited by cost...
2.
Freiburghaus T, Pawlik D, Oliveira Hauer K, Ossenkoppele R, Strandberg O, Leuzy A, et al.
Acta Neuropathol
. 2024 Sep;
148(1):44.
PMID: 39297933
[F]Flortaucipir is an FDA-approved tau-PET tracer that is increasingly utilized in clinical settings for the diagnosis of Alzheimer's disease. Still, a large-scale comparison of the in vivo PET uptake to...
3.
Wuestefeld A, Binette A, van Westen D, Strandberg O, Stomrud E, Mattsson-Carlgren N, et al.
Alzheimers Res Ther
. 2024 Sep;
16(1):204.
PMID: 39285454
Background: The medial temporal lobe (MTL) is hypothesized to be relatively spared in early-onset Alzheimer's disease (EOAD). Yet, detailed examination of MTL subfields and drivers of atrophy in amnestic EOAD...
4.
Collij L, Mastenbroek S, Mattsson-Carlgren N, Strandberg O, Smith R, Janelidze S, et al.
Nat Commun
. 2024 Sep;
15(1):8061.
PMID: 39277604
Identifying concomitant Lewy body (LB) pathology through seed amplification assays (SAA) might enhance the diagnostic and prognostic work-up of Alzheimer's disease (AD) in clinical practice and trials. This study examined...
5.
Binette A, Mammana A, Wisse L, Rossi M, Strandberg O, Smith R, et al.
Alzheimers Dement
. 2024 Sep;
20(11):7624-7634.
PMID: 39258841
Introduction: We examined the relations of misfolded alpha synuclein (α-synuclein) with Alzheimer's disease (AD) biomarkers in two large independent cohorts. Methods: We included Biomarkers for Identifying Neurodegenerative Disorders Early and...
6.
Binette A, Gaiteri C, Wennstrom M, Kumar A, Hristovska I, Spotorno N, et al.
Nat Neurosci
. 2024 Aug;
27(10):1880-1891.
PMID: 39187705
Proteomics can shed light on the dynamic and multifaceted alterations in neurodegenerative disorders like Alzheimer's disease (AD). Combining radioligands measuring β-amyloid (Aβ) plaques and tau tangles with cerebrospinal fluid proteomics,...
7.
Wisse L, Spotorno N, Rossi M, Grothe M, Mammana A, Tideman P, et al.
JAMA Neurol
. 2024 Jul;
81(10):1051-1059.
PMID: 39068668
Importance: The lack of an in vivo measure for α-synuclein (α-syn) pathology until recently has limited thorough characterization of its brain atrophy pattern, especially during early disease stages. Objective: To...
8.
Hristovska I, Binette A, Kumar A, Gaiteri C, Karlsson L, Strandberg O, et al.
medRxiv
. 2024 Jul;
PMID: 38947084
The pathophysiology underlying various manifestations of cerebral small vessel disease (cSVD) remains obscure. Using cerebrospinal fluid proximity extension assays and co-expression network analysis of 2,943 proteins, we found common and...
9.
Harper L, Strandberg O, Spotorno N, Nilsson M, Lindberg O, Hansson O, et al.
Brain Struct Funct
. 2024 Jun;
229(7):1561-1576.
PMID: 38900167
Sulcation of the anterior cingulate may be defined by presence of a paracingulate sulcus, a tertiary sulcus developing during the third gestational trimester with implications on cognitive function and disease....
10.
Soleimani-Meigooni D, Smith R, Provost K, Lesman-Segev O, Allen I, Chen M, et al.
Ann Neurol
. 2024 Jun;
96(3):476-487.
PMID: 38888212
Objective: We compared the accuracy of amyloid and [F]Flortaucipir (FTP) tau positron emission tomography (PET) visual reads for distinguishing patients with mild cognitive impairment (MCI) or dementia with fluid biomarker...